Literature DB >> 15269577

Management of maxillofacial problems in self-inflicted rifle wounds.

Fuat Yuksel1, Bahattin Celikoz, Ozge Ergun, Fatih Peker, Cengiz Açikel, Servet Ebrinc.   

Abstract

Severe gunshot wounds to the face, produced by high-velocity rifles or shotgun blasts, present a formidable challenge to reconstructive surgeons. In this study, the results of 14 cases with gunshot wounded faces caused by fire from rifles are presented, and the principles of the management of those victims were determined. These patients had attempted to commit suicide and placed the muzzles of the rifles beneath their chins. The ages of the patients ranged from 20 to 24 years, with a mean age of 22 years. These wounds were caused by close-range gunshots (<10 cm), and the missiles had high velocity (more than 800 m/second). All patients had wounds in their submental triangle areas. The exit sites of the missiles differed among patients. All exit wounds were in the angle limited by the deviation from the gun-barrel axis. After clinical and radiologic evaluation and conservative debridement of all devitalized tissues, the fractures were reduced and stabilized appropriately. Large bony defects were treated by bone grafting, and all soft tissue lesions were closed in layers. The entrance and exit sites were covered primarily after thorough debridement except one case whose defect was reconstructed with bilateral sternocleidomastoid (SCM) flaps, one for submental skin and the other for the mouth floor. Intraoral soft tissues were then repaired by primary closure, tongue flaps, or SCM flaps in case they were necessary. Free tissue transfers were not required for treatment of secondary soft-tissue problems. Resolution of tissue edema, softening of scars in time, and insertion of bone graft may improve the deformity significantly. The initial anatomic reconstruction of the existing bone skeleton and the maximal use of regional tissue for cutaneous reconstruction provide an esthetic appearance that can never be duplicated by secondary reconstruction.

Entities:  

Mesh:

Year:  2004        PMID: 15269577     DOI: 10.1097/01.sap.0000116304.70332.26

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  8 in total

1.  Facial gunshot wounds: trends in management.

Authors:  Yoav Kaufman; Patrick Cole; Larry H Hollier
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2009-05

Review 2.  [Penetrating injuries in the face and neck region. Diagnosis and treatment].

Authors:  H Maier; M Tisch; K J Lorenz; B Danz; A Schramm
Journal:  HNO       Date:  2011-08       Impact factor: 1.284

3.  Survivors of self-inflicted gunshot wounds to the head: characterization of ocular injuries and health care costs.

Authors:  Amit K Reddy; Meredith S Baker; Rachel K Sobel; David A Whelan; Keith D Carter; Richard C Allen
Journal:  JAMA Ophthalmol       Date:  2014-06       Impact factor: 7.389

4.  [Botulinum toxin A as a treatment of traumatic salivary gland fistulas].

Authors:  T Breuer; A Ferrazzini; R Grossenbacher
Journal:  HNO       Date:  2006-05       Impact factor: 1.284

5.  Early management of gunshot injuries to the face in civilian practice.

Authors:  Miriam Glapa; Jeffrey F Kourie; Dietrich Doll; Elias Degiannis
Journal:  World J Surg       Date:  2007-11       Impact factor: 3.352

6.  Penetrating Foreign Bodies in Head and Neck Trauma: A Surgical Challenge.

Authors:  Jan Oliver Voss; Nadine Thieme; Christian Doll; Stefan Hartwig; Nicolai Adolphs; Max Heiland; Jan-Dirk Raguse
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2018-04-24

7.  Management of High-energy Avulsive Ballistic Facial Injury: A Review of the Literature and Algorithmic Approach.

Authors:  Elbert E Vaca; Justin L Bellamy; Sammy Sinno; Eduardo D Rodriguez
Journal:  Plast Reconstr Surg Glob Open       Date:  2018-03-19

8.  Maxillofacial gunshot injures and their therapeutic challenges: Case series.

Authors:  Mehrnoush Momeni Roochi; Farnoosh Razmara
Journal:  Clin Case Rep       Date:  2020-04-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.